Monday 1 July 2013 at 15:15
Center for Biological Sequence Analysis, auditorium 062 in building 208
Massively parallel sequencing approaches are fundamentally impacting biomedical research in multiple areas of focused inquiry. Cancer genomics is notably impacted because of the incredible insights obtained from the tumor-to-normal comparison. We now have approaches to sequence and integrate data from whole genomes, transcriptomes and other 'omes' to derive a fuller picture of tumor heterogeneity and tumor evolution. Furthermore we can predict, in a clinical setting, outcomes and therapeutic options based on each patient's somatic genotype. My lecture will feature latest discoveries and translational insights made possible by next generation cancer genomics.
Everybody is welcome. Registration is not necessary.